| Rank |
Title |
Year |
PubWeight™‹?› |
|
1
|
Blood-brain barrier: structural components and function under physiologic and pathologic conditions.
|
2006
|
3.13
|
|
2
|
Heterogeneity of microglial activation in the innate immune response in the brain.
|
2009
|
3.04
|
|
3
|
Microglia biology in health and disease.
|
2006
|
2.53
|
|
4
|
Microglia in ALS: the good, the bad, and the resting.
|
2009
|
2.22
|
|
5
|
Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS.
|
2006
|
1.97
|
|
6
|
Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis.
|
2010
|
1.91
|
|
7
|
HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.
|
2010
|
1.87
|
|
8
|
CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson's disease.
|
2012
|
1.78
|
|
9
|
Up-regulation of BDNF in astrocytes by TNF-alpha: a case for the neuroprotective role of cytokine.
|
2006
|
1.77
|
|
10
|
Stress-induced immune dysregulation: implications for wound healing, infectious disease and cancer.
|
2006
|
1.74
|
|
11
|
Epstein-barr virus infection and multiple sclerosis: a review.
|
2010
|
1.74
|
|
12
|
CNS inflammation and macrophage/microglial biology associated with HIV-1 infection.
|
2009
|
1.73
|
|
13
|
Neurodegeneration and ageing in the HAART era.
|
2008
|
1.70
|
|
14
|
Fingolimod modulates peripheral effector and regulatory T cells in MS patients.
|
2013
|
1.59
|
|
15
|
Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson's disease.
|
2014
|
1.57
|
|
16
|
Increased accumulation of intraneuronal amyloid beta in HIV-infected patients.
|
2009
|
1.55
|
|
17
|
Divergent roles for tumor necrosis factor-alpha in the brain.
|
2007
|
1.54
|
|
18
|
Life and death of microglia.
|
2009
|
1.54
|
|
19
|
Greater than age-related changes in brain diffusion of HIV patients after 1 year.
|
2008
|
1.44
|
|
20
|
CNS infiltration of peripheral immune cells: D-Day for neurodegenerative disease?
|
2009
|
1.43
|
|
21
|
Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.
|
2011
|
1.43
|
|
22
|
Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: implications for neuroAIDS therapeutics.
|
2010
|
1.42
|
|
23
|
MDR- and CYP3A4-mediated drug-drug interactions.
|
2006
|
1.40
|
|
24
|
Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system.
|
2011
|
1.39
|
|
25
|
Nanotechnology: a focus on nanoparticles as a drug delivery system.
|
2006
|
1.37
|
|
26
|
Drugs of abuse, immune modulation, and AIDS.
|
2006
|
1.37
|
|
27
|
A transient decrease in spleen size following stroke corresponds to splenocyte release into systemic circulation.
|
2012
|
1.37
|
|
28
|
Central mechanisms of pain revealed through functional and structural MRI.
|
2012
|
1.35
|
|
29
|
Microglial activation is required for Abeta clearance after intracranial injection of lipopolysaccharide in APP transgenic mice.
|
2007
|
1.32
|
|
30
|
The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era.
|
2008
|
1.31
|
|
31
|
Regulation of microglial phagocytosis and inflammatory gene expression by Gas6 acting on the Axl/Mer family of tyrosine kinases.
|
2007
|
1.28
|
|
32
|
IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity.
|
2009
|
1.28
|
|
33
|
Cannabinoid-induced immune suppression and modulation of antigen-presenting cells.
|
2006
|
1.27
|
|
34
|
RanBPM, a scaffolding protein in the immune and nervous systems.
|
2007
|
1.25
|
|
35
|
Arboviral encephalitides: transmission, emergence, and pathogenesis.
|
2010
|
1.24
|
|
36
|
Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers.
|
2006
|
1.24
|
|
37
|
Toll-like receptors in defense and damage of the central nervous system.
|
2007
|
1.24
|
|
38
|
Microglia as a pharmacological target in infectious and inflammatory diseases of the brain.
|
2006
|
1.23
|
|
39
|
Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis.
|
2013
|
1.23
|
|
40
|
Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS.
|
2006
|
1.21
|
|
41
|
Neuroinflammation in Parkinson's disease.
|
2009
|
1.20
|
|
42
|
MFG-E8 regulates microglial phagocytosis of apoptotic neurons.
|
2008
|
1.20
|
|
43
|
Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs.
|
2006
|
1.19
|
|
44
|
Wnt/β-catenin and its diverse physiological cell signaling pathways in neurodegenerative and neuropsychiatric disorders.
|
2012
|
1.19
|
|
45
|
Modulation of immune function by morphine: implications for susceptibility to infection.
|
2006
|
1.18
|
|
46
|
Drainage of cells and soluble antigen from the CNS to regional lymph nodes.
|
2013
|
1.18
|
|
47
|
Spatial learning and memory in HIV-1 transgenic rats.
|
2007
|
1.18
|
|
48
|
Sodium benzoate, a metabolite of cinnamon and a food additive, upregulates neuroprotective Parkinson disease protein DJ-1 in astrocytes and neurons.
|
2011
|
1.17
|
|
49
|
HERVs in neuropathogenesis.
|
2010
|
1.17
|
|
50
|
Evidence for a dysregulated immune system in the etiology of psychiatric disorders.
|
2013
|
1.17
|